Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dexter

Showing results (331-340 of 340) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 340 results.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010E Marshall, A H Howell, R Powles, et al.
Molecular Phylogenetics and Evolution|June 15, 2018
Phylogenetics of moth-like butterflies (Papilionoidea: Hedylidae) based on a new 13-locus target capture probe setAkito Y Kawahara, Jesse W Breinholt, Marianne Espeland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancerA Weaver, J Chang, E Wrigley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrowL J Fairbairn, L S Lashford, E Spooncer, et al.
Blood|December 15, 1995
BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical propertiesM G Hunter, L Bawden, D Brotherton, et al.
Casopis Lekaru Ceskych|January 8, 1997
Towards gene therapy of Hurler syndromeL J Fairbairn, L S Lashford, E Spooncer, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Systematic Biology|July 28, 2025
Global climate cooling spurred skipper butterfly diversificationEmmanuel F A Toussaint, Fabien L Condamine, Ana Paula Dos Santos De Carvalho, et al.
Iscience|March 19, 2024
Comprehensive phylogeny of Pieridae butterflies reveals strong correlation between diversification and temperatureAna Paula S Carvalho, Hannah L Owens, Ryan A St Laurent, et al.
Nature Ecology & Evolution|May 15, 2023
A global phylogeny of butterflies reveals their evolutionary history, ancestral hosts and biogeographic originsAkito Y Kawahara, Caroline Storer, Ana Paula S Carvalho, et al.
Pageof 34

Showing results (331-340 of 340) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010E Marshall, A H Howell, R Powles, et al.
Molecular Phylogenetics and Evolution|June 15, 2018
Phylogenetics of moth-like butterflies (Papilionoidea: Hedylidae) based on a new 13-locus target capture probe setAkito Y Kawahara, Jesse W Breinholt, Marianne Espeland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancerA Weaver, J Chang, E Wrigley, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrowL J Fairbairn, L S Lashford, E Spooncer, et al.
Blood|December 15, 1995
BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical propertiesM G Hunter, L Bawden, D Brotherton, et al.
Casopis Lekaru Ceskych|January 8, 1997
Towards gene therapy of Hurler syndromeL J Fairbairn, L S Lashford, E Spooncer, et al.
Blood|August 26, 1998
A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapyM J Clemons, E Marshall, J Dürig, et al.
Systematic Biology|July 28, 2025
Global climate cooling spurred skipper butterfly diversificationEmmanuel F A Toussaint, Fabien L Condamine, Ana Paula Dos Santos De Carvalho, et al.
Iscience|March 19, 2024
Comprehensive phylogeny of Pieridae butterflies reveals strong correlation between diversification and temperatureAna Paula S Carvalho, Hannah L Owens, Ryan A St Laurent, et al.
Nature Ecology & Evolution|May 15, 2023
A global phylogeny of butterflies reveals their evolutionary history, ancestral hosts and biogeographic originsAkito Y Kawahara, Caroline Storer, Ana Paula S Carvalho, et al.
Pageof 34